Increasing Walking and Bright Light Exposure to Improve Sleep in Community-Dwelling Persons with Alzheimer's Disease: Results of a Randomized, Controlled Trial

被引:156
|
作者
McCurry, Susan M. [1 ]
Pike, Kenneth C. [1 ]
Vitiello, Michael V. [2 ]
Logsdon, Rebecca G. [1 ]
Larson, Eric B. [3 ]
Teri, Linda [1 ]
机构
[1] Univ Washington, Dept Psychosocial & Community Hlth, Seattle, WA 98115 USA
[2] Univ Washington, Dept Psychiat & Behav Sci, Seattle, WA 98115 USA
[3] Grp Hlth Res Inst, Seattle, WA USA
关键词
sleep; Alzheimer's disease; walking; light; adherence; NURSING-HOME RESIDENTS; PLACEBO-CONTROLLED TRIAL; INSTITUTIONALIZED PATIENTS; PHYSICAL-ACTIVITY; DEMENTIA; DISTURBANCES; PREDICTORS; MELATONIN; INSOMNIA; CAREGIVERS;
D O I
10.1111/j.1532-5415.2011.03519.x
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
OBJECTIVES: To test the effects of walking, light exposure, and a combination intervention (walking, light, and sleep education) on the sleep of persons with Alzheimer's disease (AD). DESIGN: Randomized, controlled trial with blinded assessors. SETTING: Independent community living. PARTICIPANTS: One hundred thirty-two people with AD and their in-home caregivers. INTERVENTIONS: Participants were randomly assigned to one of three active treatments (walking, light, combination treatment) or contact control and received three or six in-home visits. MEASUREMENTS: Primary outcomes were participant total wake time based on wrist actigraphy and caregiver ratings of participant sleep quality on the Sleep Disorders Inventory (SDI). Secondary sleep outcomes included additional actigraphic measurements of sleep percentage, number of awakenings, and total sleep time. RESULTS: Participants in walking (P = .05), light (P = .04), and combination treatment (P = .01) had significantly greater improvements in total wake time at posttest (effect size 0.51-0.63) than controls but no significant improvement on the SDI. Moderate effect size improvements in actigraphic sleep percentage were also observed in active treatment participants. There were no significant differences between the active treatment groups and no group differences for any sleep outcomes at 6 months. Participants with better adherence (4 d/wk) to walking and light exposure recommendations had significantly less total wake time (P = .006) and better sleep efficiency (P = .005) at posttest than those with poorer adherence. CONCLUSION: Walking, light exposure, and their combination are potentially effective treatments for improving sleep in community-dwelling persons with AD, but consistent adherence to treatment recommendations is required. J Am Geriatr Soc 59: 1393-1402, 2011.
引用
收藏
页码:1393 / 1402
页数:10
相关论文
共 50 条
  • [21] Inflammatory bowel disease medication use among community-dwelling persons with and without Alzheimer's disease
    Heikkila, Tuulia
    Tolppanen, Anna-Maija
    Koponen, Marjaana
    Hartikainen, Sirpa
    Tiihonen, Miia
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2020, 29 : 290 - 290
  • [22] Effects of a Multicomponent Frailty Prevention Program in Prefrail Community-Dwelling Older Persons: A Randomized Controlled Trial
    Yu, Ruby
    Tong, Cecilia
    Ho, Florence
    Woo, Jean
    JOURNAL OF THE AMERICAN MEDICAL DIRECTORS ASSOCIATION, 2020, 21 (02) : 294.e1 - 294.e10
  • [23] Use of strong opioids among community-dwelling persons with and without Alzheimer's disease in Finland
    Bell, J. Simon
    Laitinen, Marja-Liisa
    Lavikainen, Piia
    Lonnroos, Eija
    Uosukainen, Hanna
    Hartikainen, Sirpa
    PAIN, 2011, 152 (03) : 543 - 547
  • [24] Description of behaviors emerging in community-dwelling persons with Alzheimer's disease over 12 months
    Gamst, A
    Thomas, RG
    Patterson, M
    Schneider, L
    ANNALS OF NEUROLOGY, 2000, 48 (03) : 419 - 420
  • [25] Nationwide study of antipsychotic use among community-dwelling persons with Alzheimer's disease in Finland
    Laitinen, Marja-Liisa
    Bell, J. Simon
    Lavikainen, Piia
    Lonnroos, Eija
    Sulkava, Raimo
    Hartikainen, Sirpa
    INTERNATIONAL PSYCHOGERIATRICS, 2011, 23 (10) : 1623 - 1631
  • [26] Antipsychotic Use and the Risk of Hip Fracture Among Community-Dwelling Persons With Alzheimer's Disease
    Koponen, Marjaana
    Taipale, Heidi
    Lavikainen, Piia
    Tanskanen, Antti
    Tiihonen, Jari
    Tolppanen, Anna-Maija
    Ahonen, Riitta
    Hartikainen, Sirpa
    JOURNAL OF CLINICAL PSYCHIATRY, 2017, 78 (03) : E257 - +
  • [27] Antipsychotic Use And The Risk Of Hip Fracture Among Community-Dwelling Persons With Alzheimer's Disease
    Koponen, Marjaana
    Taipale, Heidi
    Lavikainen, Piia
    Tanskanen, Antti
    Tiihonen, Jari
    Tolppanen, Anna-Maija
    Ahonen, Riitta
    Hartikainen, Sirpa
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2016, 25 : 361 - 362
  • [28] Incidence and Prevalence of Antiepileptic Medication Use in Community-Dwelling Persons with and without Alzheimer's Disease
    Sarychevaa, Tatyana
    Taipale, Heidi
    Lavikainen, Piia
    Tiihonen, Jari
    Tanskanen, Antti
    Hartikainen, Sirpa
    Tolppanen, Anna-Maija
    JOURNAL OF ALZHEIMERS DISEASE, 2018, 66 (01) : 387 - 395
  • [29] Incidence of antipsychotic use in relation to diagnosis of Alzheimer's disease among community-dwelling persons
    Koponen, Marjaana
    Tolppanen, Anna-Maija
    Taipale, Heidi
    Tanskanen, Antti
    Tiihonen, Jari
    Johnell, Kristina
    Fastbom, Johan
    Ahonen, Riitta
    Hartikainen, Sirpa
    BRITISH JOURNAL OF PSYCHIATRY, 2015, 207 (05) : 444 - 449
  • [30] Methylphenidate for Apathy in Community-Dwelling Older Veterans With Mild Alzheimer's Disease: A Double-Blind, Randomized, Placebo-Controlled Trial
    Padala, Prasad R.
    Padala, Kalpana P.
    Lensing, Shelly Y.
    Ramirez, Daniel
    Monga, Varun
    Bopp, Melinda M.
    Roberson, Paula K.
    Dennis, Richard A.
    Petty, Frederick
    Sullivan, Dennis H.
    Burke, William J.
    AMERICAN JOURNAL OF PSYCHIATRY, 2018, 175 (02): : 159 - 168